X0306 4 2021-04-01 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001237676 VANCE DOLLY RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP Corp. Affairs, G.C., Sect. Stock Option (Right to Buy) 2.42 2021-04-01 4 A 0 37500 0 A 2030-02-06 Common Stock 37500 37500 D The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on February 6, 2020. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On April 1, 2021, it was determined that the performance metric had been met. The option was fully vested on April 1, 2021, the date the performance metric had been met. /s/Dolly Vance 2021-04-02